You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 166 No. 17, September 25, 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in this journal
 Topic Collections
 •Aging/ Geriatrics
 •Men's Health
 •Anemias
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Erythropoietin Resistance During Androgen Deficiency

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The discussion by Spivak1 of chronic anemias in the elderly would have been more complete if it had included consideration of the potential contribution by hypogonadism to these anemias in older men.

Male hypogonadism characteristically is accompanied by decreasing red blood cell mass and develops frequently with advancing age, having been documented in 25% of men with chronic renal failure (CRF)2 and many men with malignancies, including 80% of those receiving sustained-action opioids.3 Hematocrit levels in hypogonadal men improve during replacement testosterone therapy because of a combination of androgen stimulation of erythropoietin (EPO) production and direct stimulation of androgen-dependent erythropoietic cells. Among older men, however, testosterone levels are rarely examined as a factor potentially contributing to anemia, even though the origin of these anemias remains unknown in a large percentage.

Before EPO therapy became available, androgens were widely used to treat many chronic anemias including the anemia of CRF, a . . . [Full Text of this Article]


AUTHOR INFORMATION
Harry W. Daniell, MD



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED LETTERS

Erythropoietin Resistance During Androgen Deficiency—Reply
Jerry L. Spivak
Arch Intern Med. 2006;166(17):1923-1924.
EXTRACT | FULL TEXT  

Erythropoietin Levels and Androgens Use: What Is Their Relationship in the Correction of Anemia?
Charles J. Diskin
Arch Intern Med. 2007;167(3):309.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Erythropoietin Levels and Androgens Use: What Is Their Relationship in the Correction of Anemia?
Diskin
Arch Intern Med 2007;167:309-309.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.